Log in to save to my catalogue

Long-Term Clinical Benefits of Neoadjuvant Chemotherapy in Women With Locally Advanced Cervical Canc...

Long-Term Clinical Benefits of Neoadjuvant Chemotherapy in Women With Locally Advanced Cervical Canc...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2579082620

Long-Term Clinical Benefits of Neoadjuvant Chemotherapy in Women With Locally Advanced Cervical Cancer: Validity of Pathological Response as Surrogate Endpoint of Survival

About this item

Full title

Long-Term Clinical Benefits of Neoadjuvant Chemotherapy in Women With Locally Advanced Cervical Cancer: Validity of Pathological Response as Surrogate Endpoint of Survival

Publisher

England: by the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology

Journal title

International journal of gynecological cancer, 2015-10, Vol.25 (8), p.1468-1475

Language

English

Formats

Publication information

Publisher

England: by the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology

More information

Scope and Contents

Contents

ObjectiveNeoadjuvant chemotherapy (NACT) is a valid treatment option for women with locally advanced cervical cancer (LACC). This study aims to evaluate the impact of sociodemographic factors, clinical factors, and NACT regimens on survival endpoints. The role of pathological response to NACT as a surrogate endpoint of survival was also assessed.Ma...

Alternative Titles

Full title

Long-Term Clinical Benefits of Neoadjuvant Chemotherapy in Women With Locally Advanced Cervical Cancer: Validity of Pathological Response as Surrogate Endpoint of Survival

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2579082620

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2579082620

Other Identifiers

ISSN

1048-891X

E-ISSN

1525-1438

DOI

10.1097/IGC.0000000000000515

How to access this item